Search

everythinglearnresearchcommunity

for

Search:↓

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

miR-218-5p helps skin and hair growth by targeting SFRP2 and activating a specific signaling pathway.

Targeting THY1 can improve skin repair and healing.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

New psoriasis treatments are effective but come with side effects and risks.

A rare genetic mutation found in an Indian family can be detected through prenatal screening.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

New hair can grow from large wounds in mice, but less so as they age, involving reprogramming of skin cells and specific molecular pathways.

SHISA6 helps maintain certain stem cells in mouse testes by blocking signals that would otherwise cause them to differentiate.

Deferoxamine may help protect inner ear cells from damage caused by oxidative stress.

Minoxidil solution helps hair regrowth in alopecia areata, with 5% being more effective.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Hair can regrow in large wounds through a process similar to how hair forms in embryos, and understanding this could lead to new treatments for hair loss or scarring.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

ASH2L is essential for skin and hair development.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Cooling with antioxidants helps protect hair during chemotherapy.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.